The question underlying the work is one of the oldest in science: how could life have emerged from non-living matter? For a minimal cell to exist, Prof. Göpfrich explains, it must at least retain its genetic material while also being capable of change. Creating such a minimal living cell from scratch using non-living components is one of the central goals of synthetic biology, the field in which Göpfrich and her research group at the ZMBH work. Their chosen building blocks are RNA droplets: liquid-like, membrane-less nanostructures composed of synthetically produced ribonucleic acid that spontaneously self-assemble. Unlike conventional artificial cells enclosed in lipid membranes, these droplets rely on the intrinsic tendency of RNA molecules to condense into dense, viscous phases, much like oil droplets forming in water. That simplicity is precisely what makes them an attractive model for studying the earliest steps toward living systems.

A crucial property of these droplets is that they can encapsulate the genetic template from which they are transcribed. As William Verstraeten, a doctoral candidate in Prof. Göpfrich’s research group, notes, that establishes a basic prerequisite for a system that can evolve. The genetic blueprint and the molecular machinery reading it are held together in the same tiny compartment, so any mutation introduced into the template is immediately expressed as new RNA inside the very droplet that carries it. This coupling between genotype and phenotype at the nanoscale is something that even the simplest living cells achieve, and reproducing it in a purely synthetic, membrane-less system is a significant technical achievement in its own right.

What happened next surprised the researchers. When they deliberately modified the DNA template to introduce mutations, they expected the droplets to dissolve or lose their structural integrity. Instead, the opposite occurred: the droplets formed large cavities, known as vacuoles, which remained stable for days or even weeks. According to Göpfrich, a mutation rate of just around three percent was sufficient to produce these complex changes in the primitive synthetic cells. In other words, only a small fraction of the genetic material needed to be altered before the entire architecture of the droplet reorganized itself, sprouting internal compartments that no one had designed. The result suggests that elaborate structure can be encoded in, and triggered by, remarkably few molecular changes.

Identifying exactly which mutations were responsible required specialized expertise. The team led by Prof. Dr. Michael Platten at the German Cancer Research Center applied a specialized sequencing technology to determine which genetic changes produced the structural transformations inside the droplets. This analysis made it possible to create a model mutant, a defined genetic sequence whose introduction reliably reproduces the vacuole-forming effect. The ability to reproduce the phenotype at will transforms the observation from a curiosity into a tool: the researchers can now program droplet architecture by writing specific sequences into the template, effectively using mutation as a design language for synthetic cells.

The physical mechanism behind the cavities was worked out in collaboration with Prof. Dr. Christoph Weber from the Institute of Physics at the University of Augsburg. As he explains, the vacuoles form when more and more new RNA enters the already viscous interior of the droplets during transcription. The rapid accumulation of mass can cause local instabilities, from which the cavities form. In essence, the mutated RNA sequences produce transcripts that pile up inside the crowded droplet faster than the condensed phase can accommodate them, and the resulting mechanical stress tears open voids within the droplet body. The experiments confirmed that this process is subject to strict size and composition thresholds: vacuole formation requires RNA droplets to have a radius of more than 20 micrometers and to contain more than approximately two percent genetically modified material. Below those limits, the droplets remain homogeneous; above them, internal compartments reliably appear.

The consequences of those internal cavities extend far beyond appearance. Further investigations showed that the vacuoles redistribute mass inside the droplets, producing tiny movements on the micrometer scale. Mutated RNA droplets traveled significantly farther than their non-mutated counterparts and collided with one another more frequently. Those collisions had a consequential outcome: the droplets fused and grew. In a population of synthetic cells, therefore, the mutants are effectively more mobile and more interactive, qualities that in an evolutionary scenario could translate into a genuine advantage. The vacuoles also serve a storage function. As Göpfrich points out, they take up small molecules and can store this cargo inside them, giving the otherwise featureless droplets something analogous to internal organelles, compartments in which specific chemistry could in principle be concentrated and protected.

For Göpfrich, the deeper lesson is architectural. Mutagenesis, she emphasizes, provides a new architecture and new functions that would be very difficult to design and build from scratch. Traditional synthetic biology assembles systems part by part, an approach that becomes exponentially harder as the desired functions grow more complex. The Heidelberg results suggest an alternative strategy: encode a simple starting system, let mutations accumulate, and select the variants that acquire useful behaviors. Evolution, in this view, is not merely a subject of study but a manufacturing method, one capable of discovering structural solutions that human intuition and engineering would struggle to specify in advance.

That philosophy now anchors an ambitious applied agenda. As part of Heidelberg University’s SynthImmune Cluster of Excellence, the researchers aim to harness this process of mutation and selection to generate molecular functions from minimal synthetic components. Their stated goal is to use the tool to develop synthetic immune effectors capable of evolving specific immune functions on their own. If successful, the approach could yield therapeutic molecules that adapt within the body, refining their activity through cycles of mutation and selection rather than requiring every variant to be designed at the bench. The same principle, the researchers hope, could be extended to other medical applications where evolving function outperforms fixed design.

The work also carries conceptual weight for origins-of-life research. The experiments were conducted as part of the German Research Foundation-funded Collaborative Research Centre / Transregio 392, Molecular Evolution in Prebiotic Environments, which brings together the research groups of Kerstin Göpfrich in Heidelberg and Christoph Weber in Augsburg to study how evolutionary processes could have operated before cells existed. A system in which a few percent of mutations convert a static droplet into a mobile, compartmentalized, cargo-storing structure is a concrete demonstration that the threshold for emergent complexity can be low. The research was additionally supported by the European Research Council, the International Human Frontier Science Program Organization, the Alfried Krupp von Bohlen und Halbach Foundation and the Carl-Zeiss-Stiftung. The findings, published in Nature Chemical Engineering on 7 October 2026 under the title Genetic encoding and mutagenesis of RNA droplet phenotypes, suggest that the path from chemistry to function may be shorter, and more forgiving, than anyone had assumed.

Subject of Research: Mutation-driven emergence of complex phenotypes in synthetic RNA droplet cells

Article Title: Synthetic cells: function through mutation

Article References: Synthetic cells: function through mutation. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: synthetic cells, RNA droplets, mutation, vacuoles, synthetic biology, origin of life, molecular evolution, Heidelberg University, German Cancer Research Center, Nature Chemical Engineering, SynthImmune, cargo uptake

The conceptual starting point is a fundamental limitation of cellular protein synthesis. In living cells, ribosomes and messenger RNAs meet largely by random collision, with translation initiation governed by base-pairing between the Shine-Dalgarno sequence at the start of an mRNA and the anti-Shine-Dalgarno tail of the 16S rRNA. This stochastic encounter system is remarkably versatile, but it makes it nearly impossible to optimize the entire translation apparatus for the production of one specific protein, a capability that would be enormously valuable in biotechnology, where engineered cells are often asked to churn out a single high-value polypeptide. The Illinois team asked whether the ultimate solution would be to eliminate the encounter problem altogether by fusing the gene to the machine itself.

To test this idea, the researchers constructed what they call a chimeric messenger-ribosomal RNA, or mrRNA. They appended a protein-coding sequence to the 3′ end of the 16S rRNA, creating a single RNA molecule that contains both the structural information needed to build a small ribosomal subunit and the genetic information needed to encode a protein. The design drew on decades of work on translation initiation in bacteria, including the classic discovery by Shine and Dalgarno in 1974 that the 3′-terminal sequence of 16S rRNA pairs with ribosome binding sites on mRNAs. By placing a coding region downstream of the rRNA proper, separated by a short linker, the team created a transcript in which the ribosome’s own RNA carries an open reading frame.

The critical question was whether this hybrid molecule would behave. Ribosomal RNA is heavily processed, folded, modified and assembled with dozens of proteins into functional subunits, and there was no guarantee that an rRNA carrying a bulky protein-coding appendage would survive the cell’s ribonucleases or assemble into a competent particle. The team built a library of 16S rRNA-mRNA fusions and screened for constructs in which the mrRNA was incorporated into 30S small subunits and, subsequently, into complete 70S ribosomes. Their experiments showed that the chimeric RNA was indeed processed at its ends, assembled with ribosomal proteins, and incorporated into small subunits that could bind the large subunit to form functional monosomes, which the researchers named Ribo-M.

Proof that Ribo-M actually translates its own RNA came from a series of stringent controls. The team showed that the mrRNA-encoded proteins, including variants of green fluorescent protein and the small HiBiT peptide tag used in luminescence assays, were produced only when the small subunit was functional. Mutations known to inactivate the decoding center of the 16S rRNA, such as the G530A mutation in helix 18, abolished production of the mrRNA-encoded protein, as did antibiotics that impair small subunit function, such as spectinomycin. Crucially, these same mutations did not prevent the mrRNA from being incorporated into ribosomes, ruling out the alternative explanation that the protein was being made by ordinary ribosomes reading a stray mRNA fragment released from the construct. The translation, in other words, was carried out in cis, by ribosomes assembled on the very RNA molecule that encodes the protein.

The team pushed the concept further by combining the mrRNA design with Ribo-T, a previously engineered ribosome in which the small and large subunits are tethered together by a linker RNA, allowing fully orthogonal translation systems to operate inside cells. When the protein-coding sequence was integrated into the rRNA of the tethered ribosome, the result was Ribo-TM, a single RNA scaffold that unites three functions never before combined in one molecule: encoding a protein, decoding genetic information, and catalyzing peptide bond formation. In Ribo-TM, the ribosome is simultaneously the factory, the foreman and the blueprint, a self-contained unit in which the message and the machine are physically inseparable.

Beyond its synthetic biology applications, the work speaks directly to one of the deepest puzzles in evolutionary biology. In RNA world models of life’s origin, the earliest translation systems would have faced a chicken-and-egg problem: proteins are needed to make the translation machinery efficient, but the machinery is needed to make proteins. Explaining how early protein synthesis could function reliably despite the scarcity and poor organization of its components has been a long-standing challenge. The demonstration that a ribosome can translate its own RNA shows that a single RNA molecule could, in principle, have served simultaneously as structural scaffold and genetic template, providing a plausible bridge between an RNA-only world and the protein-based biochemistry that followed. The finding resonates with recent theoretical proposals about the origin of the ribosome, including hypotheses about selfish ribosome lineages and symbiotic origins published in 2026.

The technical achievement required overcoming formidable obstacles in ribosome assembly and RNA processing. The researchers used engineered Escherichia coli strains lacking native ribosomal RNA operons, allowing them to control which rRNA variants populated the cell’s ribosomes. They employed primer extension analysis to distinguish mrRNA from native 16S rRNA, sucrose gradient fractionation to track assembly into subunits and polysomes, and chemical probing with dimethyl sulfate to verify that the chimeric RNA adopted a native-like fold within the ribosome. Mapping experiments showed that the mrRNA’s 5′ and 3′ ends were processed in ways that preserved both the mature rRNA structure and the integrity of the appended coding sequence, suggesting that the cell’s RNA processing machinery can accommodate these hybrid transcripts.

The practical implications are considerable. Because a Ribo-M or Ribo-TM ribosome is committed to translating a single, internally encoded protein, the system offers a versatile platform for orthogonal protein production, in which a dedicated subpopulation of ribosomes manufactures one product with maximal efficiency and minimal interference from the cell’s own translation program. This builds on a lineage of engineered translation systems, from the specialized ribosomes of Hui and de Boer in 1987 to the orthogonal ribosome-mRNA pairs developed by Rackham and Chin in 2005 and the tethered-subunit ribosomes introduced by Orelle and colleagues in 2015. Each generation has tightened the coupling between ribosome and message; the new work completes the arc by making them one and the same molecule. Such systems could prove especially valuable for incorporating non-canonical amino acids into proteins, expanding the genetic code for new chemistries, and for cell-free protein synthesis platforms where dedicated production lines are at a premium.

Cautions remain before the technology can be widely deployed. The fraction of cellular ribosomes carrying mrRNA is limited, translation levels from the chimeric RNA are modest compared with native mRNA-driven expression, and the researchers note that the work establishes mechanistic feasibility rather than a production-ready system. The authors have filed a pending patent application covering the Ribo-M and Ribo-TM designs, and the key plasmids and strains are being made available through Addgene, which should accelerate adoption across the synthetic biology community. Still, the conceptual breakthrough is unmistakable. A ribosome that reads its own RNA is no longer just a molecular machine but a self-referential one, and in demonstrating that such a construct can live, assemble and translate inside a bacterial cell, the Illinois team has both expanded the engineering toolkit for protein production and offered experimental support for a compelling scenario in which life’s first proteins were made by ribosomes translating themselves.

Subject of Research: Engineering ribosomes that translate proteins encoded within their own ribosomal RNA

Article Title: Rewiring the ribosome to translate proteins encoded in its own RNA

Article References: Alizadeh, K., Klepacki, D., Vázquez-Laslop, N., & Mankin, A. S. (2026). Rewiring the ribosome to translate proteins encoded in its own RNA. Nature. https://doi.org/10.1038/s41586-026-10962-1

Image Credits: AI Generated

DOI: 10.1038/s41586-026-10962-1

Keywords: ribosome, translation, ribosomal RNA, synthetic biology, mRNA, Ribo-M, Ribo-T, orthogonal translation, RNA world, origin of life, protein synthesis, molecular engineering